Pancreatic Cancer Research

ResearcherFriedrich-Alexander-Universität Erlangen-NürnbergNo recent work listed

Stefan Lyer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2338-1136; OpenAlex author ID A5039200412. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids. Last author DOI 10.3390/ma16072906↗
  2. New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2174/0929867324666170510150124↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Harald Mangge · 2 shared papers, 2017–2023 · strength 0.27
  2. Hai Yang · 1 shared paper, 2023 · strength 0.18
  3. Jonas Dinter · 1 shared paper, 2023 · strength 0.18
  4. Christian P. Pilarsky · 1 shared paper, 2023 · strength 0.18
  5. Johannes Haybaeck · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.